Coherus Oncology (CHRS) Asset Utilization Ratio (2014 - 2026)
Coherus Oncology's Asset Utilization Ratio came in at 0.22 for Q2 2026, up 185.4% from 0.08 a year earlier and up 24.6% from the prior quarter.
Powered by 
Analysis
Coherus Oncology (CHRS) Asset Utilization Ratio (2014 - 2026) Analysis & Trends
For FY2025, Coherus Oncology's Asset Utilization Ratio was 0.12, up 143.7% from FY2024.
- Going back by year, Asset Utilization Ratio was 0.05 in FY2024 (-89.4%), 0.46 in FY2023 (+27.4%), 0.36 in FY2022 (-15.3%) and 0.43 in FY2021 (-43.6%).
- The Q2 2026 figure represents the highest quarterly Asset Utilization Ratio since Q2 2024.
- Year-over-year, Asset Utilization Ratio has increased for three consecutive quarters, with growth averaging 8.7% over the last eight quarters.
- The fastest year-over-year change in Asset Utilization Ratio over five years came in Q2 2026 (growth of 185.4%), and the weakest in Q4 2024 (a decline of 86.9%).
- Business Quant data shows CHRS's Asset Utilization Ratio at 0.18 (Q1 2026), 0.11 (Q4 2025) and 0.08 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,122.91 Bn | 1,091.50 Bn | 19.71 Bn | 0.62 |
| 2 | Johnson & Johnson | 615.09 Bn | 533.62 Bn | 17.26 Bn | 0.49 |
| 3 | AbbVie | 504.75 Bn | 477.86 Bn | 12.70 Bn | 0.47 |
| 4 | Merck | 360.18 Bn | 314.55 Bn | 12.21 Bn | 0.52 |
| 5 | Novartis Ag | 292.05 Bn | 256.04 Bn | 11.24 Bn | 0.46 |
| 6 | Astrazeneca | 256.09 Bn | 229.78 Bn | 12.86 Bn | 0.51 |
| 7 | Amgen | 233.63 Bn | 189.02 Bn | 7.24 Bn | 0.40 |
| 8 | Gilead Sciences | 194.49 Bn | 168.69 Bn | 6.22 Bn | 0.58 |
| 9 | Pfizer | 168.35 Bn | 114.99 Bn | 10.94 Bn | 0.31 |
| 10 | Coherus Oncology | 155.59 Mn | -480.55 Mn | 10.07 Mn | 0.22 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.22 |
| Mar 31, 2026 | 0.18 |
| Dec 31, 2025 | 0.11 |
| Sep 30, 2025 | 0.08 |
| Jun 30, 2025 | 0.08 |
| Mar 31, 2025 | 0.08 |
| Dec 31, 2024 | 0.06 |
| Sep 30, 2024 | 0.19 |
| Jun 30, 2024 | 0.25 |
| Mar 31, 2024 | 0.33 |
| Dec 31, 2023 | 0.42 |
| Sep 30, 2023 | 0.40 |
| Jun 30, 2023 | 0.42 |
| Mar 31, 2023 | 0.42 |
| Dec 31, 2022 | 0.41 |
| Sep 30, 2022 | 0.44 |
| Jun 30, 2022 | 0.48 |
| Mar 31, 2022 | 0.48 |
| Dec 31, 2021 | 0.46 |
| Sep 30, 2021 | 0.49 |
API Access
Coherus Oncology Asset Utilization Ratio API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=CHRS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "asset-utilization-ratio", "ticker": "CHRS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=CHRS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();